CR
CRVAF.US CurveBeam AI Limited
- Market cap
- USD 20.9M
- P/E
- -
- P/B
- 0.92x
- ROE
- -67.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is CRVAF.US undervalued?
Graham numberThe Graham number of CurveBeam AI Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CurveBeam AI Limited fundamental analysis
No fundamental analysis for CurveBeam AI Limited yet.
CurveBeam AI Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CurveBeam AI Limited
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the …
Full company profileCurveBeam AI Limited financial statements
CurveBeam AI Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 7.20M | 7.42M | 8.06M | 6.53M | 8.67M |
| Gross Profit | 3.22M | 3.99M | 4.39M | 3.01M | 2.85M |
| Operating Income | -7.62M | -12.0M | -18.8M | -23.9M | -20.4M |
| EBITDA | - | -9.04M | -43.5M | -18.6M | -14.9M |
| Net Income | -6.75M | -9.62M | -51.2M | -23.1M | -18.8M |
| EPS | -0.02 | -0.03 | -0.74 | -0.07 | -0.04 |
| Balance Sheet | |||||
| Total Assets | 0.00 | 0.00 | 61.4M | 63.3M | 53.2M |
| Total Liabilities | 0.00 | 0.00 | 109M | 24.4M | 25.4M |
| Shareholders' Equity | 0.00 | 0.00 | -48.1M | 38.9M | 27.8M |
| Cash & Short-term Investments | - | - | 5.16M | 6.45M | 1.64M |
| Cash Flow | |||||
| Capital Expenditure | 295K | 306K | 842K | 324K | 15.3K |
| Free Cash Flow | -4.83M | -10.5M | -22.5M | -22.2M | -13.0M |
| Ratios | |||||
| ROE | - | - | - | -59.4% | -67.8% |
| ROA | - | - | -83.5% | -36.5% | -35.4% |
| Net Profit Margin | -93.7% | -129.7% | -635.9% | -353.9% | -217.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CurveBeam AI Limited dividends
CurveBeam AI Limited has not paid dividends in the last 5 fiscal years.
Who owns CurveBeam AI Limited
- Insiders 44.02%
- Institutions 12.77%
- Public & others 43.20%
- Shares outstanding 387M
- Free float 266M
CurveBeam AI Limited company profile
- Company name
- CurveBeam AI Limited
- Ticker
- CRVAF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- June
- Address
- 2800 Bronze Drive, Hatfield, PA, United States, 19440
- Phone
- 267 483 8081
- Website
- curvebeamai.com
About CurveBeam AI Limited
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
CurveBeam AI Limited management
9- Mr. Gregory Wayne Brown BSc, MBACEO, MD & Director · born 1964
- Mr. Ura Phillip Stephen AucklandCFO & Company Secretary
- Mr. Arun Bahadur SinghCOO, CTO, President of US & Europe Division and Executive Director · born 1959
- Dr. Aloys MbalaCo-Founder
- Mr. Ali GhasemzadehCo-Founder
- Mr. S. Turner DeanChief Sales Officer
- Ms. Vinti SinghVice President of Marketing
- Dr. Yu Peng B.S., Ph.D.Chief Technology Officer (Artificial Intelligence) & Executive Director
- Prof. Ego SeemanMedical Director - Endocrinology